Get Level 2

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Nationwide Ccds Share Price
  4. Nationwide Ccds Share Regulatory News
  5. Interim Results September 2025

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Nationwide Ccds Information

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Interim Results September 2025

20 Nov 2025 07:00

RNS Number : 2563I
Nationwide Building Society
20 November 2025
 

 

 

20 November 2025

 

 

 

Nationwide Building Society

Interim Results for the period ended 30 September 2025

 

 

Nationwide Building Society today released its Interim Results for the six-month period ended 30 September 2025.

 

The results will shortly be available via the following link:

 

https://www.nationwide.co.uk/about-us/governance-reports-and-results/results-and-accounts/

 

The document has also been submitted in unedited full text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

For further information, please contact:

 

Media queries:

 

Sara Batchelor

Mobile: +44 (0)7785 344 137

Sara.Batchelor@nationwide.co.uk 

 

Harry Yeates

Mobile: +44 (0)7824 801 980

Harry.Yeates@nationwide.co.uk

 

Investor queries:

 

Sarah Abercrombie

Mobile: +44 (0)7587 886 500

Sarah.Abercrombie@nationwide.co.uk

 

Vikas Sidhu

Mobile: +44 (0)7738 273 287

Vikas.Sidhu@nationwide.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DKLFFEFLZFBV
12345678910
Date   Source Headline
26th Jun 20261:52 pmRNSPublication of Final Terms
25th Jun 202612:21 pmRNSAdmission to Trading
23rd Jun 202612:03 pmRNSPublication of Final Terms
23rd Jun 202611:04 amRNSAdmission to Trading
19th Jun 20264:43 pmRNSPublication of Final Terms
15th Jun 20261:30 pmRNSNotice to Covered Bondholders
15th Jun 202612:40 pmRNSPublication of a Supplementary Prospectus
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IDWP
Ishr Dm Prop
LSE
1.33%
MYI
Murray International
LSE
0.14%
KIE
Kier
LSE
-0.18%
PUR
PUR.L
LSE
0.00%
SHRS
Shires Inc.
LSE
0.00%
Trending
SCLP
Scancell Holdings
LSE
-3.16%
IMM
Immupharma
LSE
0.54%
EZJ
easyJet
LSE
1.53%
AVCT
Avacta Group
LSE
3.95%
MAC
Marechale Cap.
LSE
0.00%